S

Summit Therapeutics

Develops and commercializes therapeutic medicines

Associate Director - CMC Statistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timePrinceton, NJ, USA

About the Job

Requirements

  • A master's degree in Statistics, Biostatistics, Applied Mathematics, Data Science, Engineering, Pharmaceutical Sciences, or a related quantitative discipline is considered; a PhD, ScD, or equivalent is preferred.
  • A minimum of 10 years of industry experience applying statistics to biologics CMC activities in a biopharmaceutical or biotechnology setting is required.
  • Direct, substantial experience with specification setting, stability trending and shelf-life assessment, analytical method bridging, and comparability assessment is required.
  • Demonstrated experience supporting biologic drug substance and drug product programs and working with analytical, manufacturing, quality, and regulatory data is required.
  • Strong command of statistical methods relevant to CMC, including regression, analysis of variance, mixed models, equivalence and non-inferiority approaches, tolerance intervals, control charts, capability analysis, multivariate methods, and design of experiments is required.
  • Experience applying statistical principles to analytical method qualification, validation, transfer, lifecycle monitoring, and investigations is required.
  • Working knowledge of applicable ICH guidance, FDA and EMA expectations, cGMP requirements, and data-integrity standards for biologics development and commercialization is required.
  • Proficiency with one or more statistical software platforms such as JMP, SAS, R, Python, or Minitab, including the ability to produce reproducible, traceable analyses and effective data visualizations, is required.
  • Experience authoring or reviewing technical protocols, statistical analysis plans, reports, regulatory submission content, and health authority responses is required.
  • The candidate must be able to explain statistical concepts and business implications to non-statistical audiences.
  • The candidate must be able to work independently, exercise scientific judgment, influence cross-functional teams, and manage multiple priorities with attention to quality and detail.

Responsibilities

  • Serve as the CMC statistical subject matter expert for biologic drug substance and drug product development, registration, commercialization, and lifecycle management.
  • Develop and execute statistical strategies for specification setting, including establishing and justifying release and stability acceptance criteria, control limits, tolerance intervals, and clinically and process-relevant decision rules.
  • Lead statistical evaluation of stability data, including trend analysis, shelf-life and retest-period modeling, protocol design, pooling assessments, extrapolation, and ongoing stability monitoring.
  • Design and analyze analytical method bridging, transfer, qualification, and validation studies; define acceptance criteria and assess equivalence, comparability, precision, accuracy, linearity, range, robustness, and intermediate precision.
  • Lead statistical planning and analysis for analytical and product comparability assessments associated with process changes, manufacturing-site transfers, scale changes, method changes, and post-approval activities.
  • Provide statistical support for analytical control strategies, critical quality attribute assessments, process characterization, process validation, continued process verification, and product quality reviews.
  • Apply appropriate methods such as regression, analysis of variance, mixed models, equivalence testing, multivariate analysis, design of experiments, control charts, capability analysis, and risk-based sampling to CMC datasets.
  • Support deviations, out-of-specification and out-of-trend investigations, root-cause assessments, CAPAs, and change controls through objective statistical analysis and clear interpretation.
  • Author and review statistical analysis plans, protocols, reports, technical memos, procedures, regulatory submission sections, and responses to health authority questions.
  • Ensure statistical approaches align with applicable ICH guidance, global regulatory expectations, cGMP requirements, data-integrity principles, and internal quality standards.
  • Partner with external CDMOs, CROs, and testing laboratories to align study designs, data standards, analyses, deliverables, and timelines; critically review vendor analyses and resolve technical issues.
  • Develop fit-for-purpose statistical tools, templates, standards, and governance approaches that improve consistency, efficiency, traceability, and data-driven decision-making across CMC.
  • Communicate complex statistical concepts and conclusions to technical and non-technical stakeholders, influence cross-functional decisions, and present recommendations to senior leadership.
  • Manage multiple priorities in a fast-paced, resource-lean environment and perform other duties as assigned.

Desired Qualifications

  • Experience with monoclonal antibodies, bispecific antibodies, or other complex biologics.
  • Experience supporting late-stage development, BLA/MAA submissions, commercial readiness, process validation, PPQ, post-approval changes, and product lifecycle management.
  • Experience operating in an outsourced or virtual development model with CDMOs, CROs, and external testing laboratories.
  • Experience establishing CMC statistical standards, procedures, templates, analysis plans, or governance frameworks.
  • Familiarity with data visualization and reporting tools such as Spotfire, Tableau, or comparable platforms.

About the Company

Summit Therapeutics

Develops and commercializes therapeutic medicines

Summit Therapeutics conducts end-to-end drug development, from identifying promising candidates to regulatory approval and commercialization. It relies on an in-house team of scientists and administrators and uses selective partnerships to advance products. Its therapies aim to improve both quality and length of life for patients with serious health needs. By controlling the development and commercialization process in-house, Summit seeks to speed development, reduce costs, and build a lasting healthcare organization with strong market presence and value for patients, clinicians, caregivers, and shareholders.

Company size
51-200
Company stage
Not listed
Total funding
Not listed
Headquarters
Menlo Park, CA
Founded
2003

Recently Posted Jobs

Explore more opportunities at Summit Therapeutics

See more jobs